Madrigal Pharmaceuticals, Inc. SEC filings MDGL

Madrigal Pharmaceuticals, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Nov 12, 2010. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Madrigal Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Aug 12, 2026 Aug 11, 2026
10-Q Quarterly report Jul 30, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 30, 2026 Jul 30, 2026
S-8 Employee stock plan registration Jun 17, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2026 Jun 16, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 6, 2026 May 6, 2026
8-K Current report
Officer or director change
Apr 28, 2026 Apr 22, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 17, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 19, 2026 Feb 19, 2026
8-K Current report
Material agreement
Jan 30, 2026 Jan 29, 2026
8-K Current report
Officer or director change
Dec 11, 2025 Dec 5, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 4, 2025 Nov 4, 2025
S-8 Employee stock plan registration Sep 11, 2025 —
10-Q Quarterly report Aug 5, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Regulation FD disclosure
Jul 30, 2025 Jul 30, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
Jul 22, 2025 Jul 17, 2025
S-8 Employee stock plan registration Jun 20, 2025 —
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 20, 2025
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 20, 2025
8-K Current report
Officer or director change
Apr 17, 2025 Apr 16, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 11, 2025 Mar 9, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
8-K Current report
Results of operations
Jan 13, 2025 Jan 13, 2025
S-8 Employee stock plan registration Oct 31, 2024 —
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 27, 2024 Jun 25, 2024
8-K Current report
Material agreement, Agreement ended, Other events
May 7, 2024 May 7, 2024
424B3 Prospectus May 7, 2024 —
424B5 Prospectus supplement May 7, 2024 —
S-3ASR Automatic shelf registration May 7, 2024 —
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 25, 2024
8-K Current report
Other events
Apr 2, 2024 Mar 27, 2024
8-K Current report
Material agreement
Mar 20, 2024 Mar 18, 2024
424B5 Prospectus supplement Mar 20, 2024 —
424B5 Prospectus supplement Mar 18, 2024 —
8-K Current report
Regulation FD disclosure, Other events
Mar 15, 2024 Mar 14, 2024
8-K Current report
Officer or director change
Feb 28, 2024 Feb 22, 2024
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
10-K Annual report Feb 28, 2024 Dec 31, 2023
UPLOAD Letter from the SEC Jan 25, 2024 —
CORRESP Letter to the SEC Jan 17, 2024 —
8-K Current report
Other events
Jan 8, 2024 Jan 8, 2024
UPLOAD Letter from the SEC Jan 3, 2024 —
CORRESP Letter to the SEC Dec 14, 2023 —
CORRESP Letter to the SEC Dec 8, 2023 —
UPLOAD Letter from the SEC Nov 21, 2023 —
8-K Current report
Results of operations
Nov 6, 2023 Nov 6, 2023
10-Q Quarterly report Nov 6, 2023 Sep 30, 2023
8-K Current report
Material agreement
Oct 2, 2023 Sep 28, 2023
424B5 Prospectus supplement Oct 2, 2023 —
424B5 Prospectus supplement Sep 28, 2023 —
8-K Current report
Officer or director change
Sep 25, 2023 Sep 20, 2023
8-K Current report
Officer or director change
Sep 14, 2023 Sep 8, 2023
8-K Current report
Officer or director change
Sep 13, 2023 Sep 7, 2023
8-K Current report
Other events
Sep 13, 2023 Sep 12, 2023
S-8 Employee stock plan registration Sep 11, 2023 —
424B3 Prospectus Aug 8, 2023 —
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 17, 2023 Jul 17, 2023
8-K Current report
Other events
Jun 30, 2023 Jun 30, 2023
8-K Current report
Officer or director change
Jun 20, 2023 Jun 15, 2023
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 20, 2023 Jun 15, 2023
424B5 Prospectus supplement May 9, 2023 —
8-K Current report
Material agreement
May 9, 2023 May 9, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
DEFA14A Additional proxy material May 1, 2023 —
DEF 14A Proxy statement May 1, 2023 —
PRE 14A Preliminary proxy statement Apr 21, 2023 —
10-K/A Amended annual report Mar 3, 2023 Dec 31, 2022
8-K Current report
Results of operations
Feb 23, 2023 Feb 23, 2023
10-K Annual report Feb 23, 2023 Dec 31, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
Feb 9, 2023 Feb 3, 2023
8-K Current report
Other events
Jan 10, 2023 Jan 6, 2023
424B5 Prospectus supplement Dec 23, 2022 —
8-K Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure, Other events
Dec 23, 2022 Dec 19, 2022
8-K Current report
Regulation FD disclosure, Other events
Dec 19, 2022 Dec 19, 2022
10-Q Quarterly report Nov 3, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 3, 2022 Nov 3, 2022
8-K Current report
Results of operations
Aug 4, 2022 Aug 4, 2022
10-Q Quarterly report Aug 4, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 17, 2022 Jun 15, 2022
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Material agreement, New debt, Unregistered share sale
May 9, 2022 May 9, 2022
8-K Current report
Results of operations
May 9, 2022 May 9, 2022
DEFA14A Additional proxy material May 2, 2022 —
DEF 14A Proxy statement May 2, 2022 Jun 15, 2022
10-K Annual report Feb 24, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 24, 2022 Feb 24, 2022
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
S-8 Employee stock plan registration Jun 29, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 21, 2021 Jun 17, 2021
8-K Current report
Material agreement
Jun 1, 2021 Jun 1, 2021
424B5 Prospectus supplement Jun 1, 2021 —
S-3ASR Automatic shelf registration Jun 1, 2021 —
8-K Current report
Officer or director change, Regulation FD disclosure
May 18, 2021 May 17, 2021
8-K Current report
Results of operations
May 6, 2021 May 6, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
DEFA14A Additional proxy material Apr 30, 2021 —
DEF 14A Proxy statement Apr 30, 2021 Jun 17, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
S-8 Employee stock plan registration Nov 5, 2020 —
424B5 Prospectus supplement Nov 5, 2020 —
8-K Current report
Material agreement
Nov 5, 2020 Nov 5, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Shareholder vote results
Jun 18, 2020 Jun 17, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
10-Q Quarterly report May 7, 2020 Mar 31, 2020
DEF 14A Proxy statement Apr 29, 2020 Jun 17, 2020
8-K Current report
Results of operations
Feb 26, 2020 Feb 26, 2020
10-K Annual report Feb 26, 2020 Dec 31, 2019
8-K Current report
Material agreement
Dec 12, 2019 Dec 10, 2019
424B7 Filing Dec 12, 2019 —
8-K Current report
Other events
Dec 10, 2019 Dec 10, 2019
8-K Current report
Results of operations
Nov 6, 2019 Nov 6, 2019
10-Q Quarterly report Nov 6, 2019 Sep 30, 2019
8-K Current report
Results of operations
Aug 7, 2019 Aug 7, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Officer or director change
Jul 11, 2019 Jul 11, 2019
8-K Current report
Officer or director change, Shareholder vote results
Jul 2, 2019 Jun 27, 2019
DEFA14A Additional proxy material May 15, 2019 —
DEF 14A Proxy statement May 15, 2019 Jun 27, 2019
8-K Current report
Results of operations
May 8, 2019 May 8, 2019
10-Q Quarterly report May 8, 2019 Mar 31, 2019
10-K/A Amended annual report Apr 30, 2019 Dec 31, 2018
CT ORDER Filing Mar 12, 2019 —
8-K Current report
Results of operations
Feb 27, 2019 Feb 27, 2019
10-K Annual report Feb 27, 2019 Dec 31, 2018
8-K Current report
Results of operations
Nov 6, 2018 Nov 6, 2018
10-Q Quarterly report Nov 6, 2018 Sep 30, 2018
8-K Current report
Results of operations
Aug 7, 2018 Aug 7, 2018
10-Q Quarterly report Aug 7, 2018 Jun 30, 2018
8-K Current report
Shareholder vote results
Jun 22, 2018 Jun 19, 2018
8-K Current report
Material agreement
Jun 8, 2018 Jun 6, 2018
424B5 Prospectus supplement Jun 7, 2018 —
424B5 Prospectus supplement Jun 6, 2018 —
S-3ASR Automatic shelf registration Jun 5, 2018 —
8-K Current report
Other events
May 31, 2018 May 31, 2018
8-K Current report
Results of operations
May 8, 2018 May 8, 2018
10-Q Quarterly report May 8, 2018 Mar 31, 2018
S-8 Employee stock plan registration Apr 27, 2018 —
DEFA14A Additional proxy material Apr 27, 2018 —
DEF 14A Proxy statement Apr 27, 2018 Jun 19, 2018
8-K Current report
Results of operations
Mar 13, 2018 Mar 13, 2018
10-K Annual report Mar 13, 2018 Dec 31, 2017
8-K Current report
Material agreement
Dec 21, 2017 Dec 18, 2017
424B5 Prospectus supplement Dec 20, 2017 —
424B5 Prospectus supplement Dec 18, 2017 —
8-K Current report
Results of operations
Nov 9, 2017 Nov 9, 2017
10-Q Quarterly report Nov 9, 2017 Sep 30, 2017
8-K Current report
Results of operations
Aug 10, 2017 Aug 10, 2017
10-Q Quarterly report Aug 10, 2017 Jun 30, 2017
424B3 Prospectus Jul 26, 2017 —
EFFECT Filing Jul 25, 2017 —
UPLOAD Letter from the SEC Jul 21, 2017 —
CORRESP Letter to the SEC Jul 21, 2017 —
S-3 Shelf registration Jul 17, 2017 —
D Filing Jul 5, 2017 —
8-K Current report
Officer or director change, Shareholder vote results
Jul 5, 2017 Jun 29, 2017
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jun 21, 2017 Jun 20, 2017
8-K Current report
Other events
Jun 1, 2017 May 26, 2017
8-K Current report
Results of operations
May 11, 2017 May 11, 2017
10-Q Quarterly report May 11, 2017 Mar 31, 2017
DEF 14A Proxy statement Apr 28, 2017 Jun 29, 2017
8-K Current report
Results of operations
Apr 3, 2017 Apr 3, 2017
10-K Annual report Mar 31, 2017 Dec 31, 2016
10-Q/A Amended quarterly report Mar 31, 2017 Sep 30, 2016
8-K Current report
Restatement
Mar 31, 2017 Mar 27, 2017
CT ORDER Filing Mar 15, 2017 —
10-Q/A Amended quarterly report Nov 16, 2016 Sep 30, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
8-K Current report
Results of operations
Nov 14, 2016 Nov 14, 2016

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MDGL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
West Conshohocken, PA
SEC filer status
Large accelerated filer
SEC CIK
1157601
Former names
MADRIGAL PHARMACEUTICALS, INC. (until Nov 3, 2026); SYNTA PHARMACEUTICALS CORP (until Aug 1, 2016)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.